INDEPENDENT INTELLIGENCE
LATESTSEARCH ⌕
NASDAQ / LIVE COMPANY INTELLIGENCE

CAMP4 Therapeutics Corporation

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERCAMP
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / CAMP COVERAGE

What’s moving CAMP4 Therapeutics Corporation now

Current reporting with the operating signal separated from the noise.

01
Is CAMP4 THERAPEUTICS CORPORATION (CAMP) Stock Undervalued Ahead of Key CMP-002 Clinical Development Milestones?

Is CAMP4 THERAPEUTICS CORPORATION (CAMP) Stock Undervalued Ahead of Key CMP-002 Clinical Development Milestones?

Investors are testing whether CAMP4 Therapeutics Corporation’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
02
Positive Report for CAMP4 Therapeutics Corporation (CAMP) from J.P. Morgan

Positive Report for CAMP4 Therapeutics Corporation (CAMP) from J.P. Morgan

The story matters when it changes CAMP4 Therapeutics Corporation’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
03
Camp4 Therapeutics Corporation (CAMP) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Camp4 Therapeutics Corporation (CAMP) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

The story matters when it changes CAMP4 Therapeutics Corporation’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
04
CAMP4 Therapeutics Corporation (CAMP) Upgraded to Buy: Here's Why

CAMP4 Therapeutics Corporation (CAMP) Upgraded to Buy: Here's Why

The story matters when it changes CAMP4 Therapeutics Corporation’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
05
CAMP4 Therapeutics Corporation (CAMP) Upgraded to Buy: Here's What You Should Know

CAMP4 Therapeutics Corporation (CAMP) Upgraded to Buy: Here's What You Should Know

The story matters when it changes CAMP4 Therapeutics Corporation’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest CAMP filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-07 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-06 · Period 2025-09-30SEC ↗10-KAnnual financial reportFiled 2026-03-05 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-08-04 · Period 2026-08-03SEC ↗8-KMaterial company eventFiled 2026-07-27 · Period 2026-07-27SEC ↗8-KMaterial company eventFiled 2026-06-12 · Period 2026-06-10SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-04-23 · Period 2026-06-10SEC ↗4Official SEC filingFiled 2026-06-12 · Period 2026-06-10SEC ↗
EARNINGS / QUARTERLY TRACKER

CAMP4 Therapeutics Corporation, quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.